% 0.77 1.25 62.34% Earnings before Interest and taxes 34.47 16.90 19.09 -44.62% 12.96% 69.40 35.99 -48.14% Financial expense (0.15) (0.26) (0.73) 386.67% 180.77% (0.30) (0.99) 230.00% Profit before income
of staff and management to support Testing and Inspection service business, especially in eastern region. The staff cost has been increased 92.75% compared to the same period of prior year. Moreover
service. 5. Administrative expense for the Group increased as the increased in number of staff and management to support Testing and Inspection service business, especially in eastern region. The staff cost
remaining two segments, Integrated Oxides & Derivatives and Specialty Chemicals are expected to resume their earnings from unplanned shutdowns, except IPA which we believe will recover over the next 12-18
expenses 42.73 79.69 (36.96) (46.38) 104.01 147.50 (43.49) (29.49) Administrative expenses 32.34 45.05 (12.71) (28.22) 65.37 88.52 (23.15) (26.15) Earnings before interest and taxes (EBIT) (6.69) 7.28 (13.97
61.27 67.82 (6.55) (9.66) Administrative expenses 33.04 43.47 (10.43) (24.00) Earnings before interest and taxes (EBIT) 10.97 (2.70) 13.67 (506.71) Financial costs 2.77 1.09 1.69 155.39 Income tax
0.67% of revenue from operation, respectively. Such expenses increased by THB 0.23 million or 176.92% from the same period of previous year as the Group Company had incurred related expenses to support
reported net profit of Baht 24.8 million. Earnings per share was Baht 1.16. Nine-Month Period The Company reported consolidated revenues of Baht 1,296.0 million, decreased by 8.4%. Sales revenues reported
net profit of THB 24.02 million or earnings per share of THB 0.02, a decrease of THB 22.39 million or 48.25%. Details were as follows: The decrease in operating performance when comparing with the same
% EBIT (27.73) (3.27) (24.46) 748.01% Net Profit (Loss) (21.72) (0.34) (21.38) 6288.24% Basic Earnings (Loss) per Share (0.110) (0.002) (0.108) 6288.24% Performance Report The epidemic of COVID-19 affects